Open company graph database — free web & API
Login

Toa Eiyo Corporation

トーアエイヨー株式会社
Ticker
—
Listed market
—
Country
Japan
Employees (consolidated)
278
Related companies
0
§01

Basic information

BASIC
Head office
3-10-6 Hatchobori, Chuo-ku, Tokyo
Chief executive
Masahiko Deno
Capital
300,000,000  (3 100 million)
Employees (non-consolidated)
270 people
Employees (consolidated)
278 people
Start date
1943-10-01
End date
§02

Websites

1 DOMAINS
§03

Business

1
Pharmaceutical manufacturing and sales
§04

Related companies

0 COMPANIES

—

§05

Network

NETWORK
Drag to move · click to open
§06

History

180 EVENTS

Held the founding meeting (general meeting of incorporation) and decided to establish Toa Nutrition Chemical Industry Co., Ltd.Sources

Establishment of Toa Nutrition Chemical Industry Co., Ltd.Sources

Establishment of Toa Nutritional Chemistry Industry Co., Ltd. (Inherited research on extracting vitamin B2 from silkworm pupae and established a factory in Iizaka Town, Fukushima City)Sources

Date Factory begins full-scale operationSources

Signed a sales contract with Yamanochi Pharmaceutical Co., Ltd.Sources

Start of operation at Fukushima Factory (production of vitamin B2 bislazide)Sources

Conclusion of business contract with Yamanouchi Pharmaceutical (exclusive sales agreement for our products)Sources

Full-scale production of vitamin B2 using KS bacteriaSources

Start of mass production of high-unit vitamin B2 preparations (completion of Elemo Tesium and Asby culture facilities, entering full-scale vitamin B2 production)Sources

Employees' union establishedSources

Emperor Showa visited Date Factory during his tour of Tohoku regionSources

Visit of Emperor Showa to Fukushima FactorySources

Labor agreement signed with employees' unionSources

Work rules establishedSources

Date Factory awarded for safety and health excellence by Fukushima Labor Standards OfficeSources

Tokyo Sales Office establishedSources

First labor councilSources

Sales exceeded 100 million yenSources

Capital increased to 1.95 million yenSources

Date Factory awarded for hygiene excellence (Minister of Labour Award)Sources

55th Japan Vitamin Society Committee B (held at our factory hall)Sources

Awarded the Minister of Labor Award (1st National Health Week Excellent Award)Sources

10th anniversary ceremony heldSources

New food division establishedSources

Joined Tokyo Katakura Health Insurance SocietySources

Fiscal year changed to NovemberSources

Capital increased to 3 million yenSources

Received the site of Date Factory from Katakura Industries Co., Ltd.Sources

Capital increased to 7.8 million yenSources

Received the land and buildings of the warehouse and drying yard of Date Factory from Katakura Factory Co., Ltd.Sources

Sales exceeded 200 million yenSources

Completion of tank culture facilities (start of production of coenzyme-type vitamin B2 and FAD)Sources

Held the 15th anniversary ceremonySources

Date Factory received the first-class award for record of no accidentsSources

Date Factory received the Safety Progress Award from the Minister of LabourSources

Fukushima Prefecture Pharmaceutical Sports Tournament overall victorySources

Awarded the Minister of Labor Award (2nd National Safety Week Progress Award)Sources

Synthetic reaction vessel installed at Date Factory, starting FAD synthesisSources

Sales exceeded 300 million yenSources

Completion of sterile room expansion (start of production of ATP preparations and others)Sources

Capital increased to 19.5 million yenSources

Table tennis club received the Excellent Sports Organization Award from the Governor and Board of EducationSources

Opened Osaka OfficeSources

Sales exceeded 500 million yenSources

Capital increased to 50 million yenSources

Research institute completed within Date Factory siteSources

Completion of new research laboratorySources

Renamed Date Factory to Fukushima FactorySources

Capital increased to 100 million yenSources

Synthetic factory, formulation factory, energy building, and animal testing building completed at Fukushima FactorySources

Sapporo Office OpeningSources

Sales Exceeded 1 Billion YenSources

Completion of new formulation and first synthesis factoriesSources

Fukuoka Office OpeningSources

Fukushima Factory Completed with Large Hall, Cafeteria Building, Office Building, Welfare BuildingSources

Completion of welfare building, administrative building, cafeteria, and hallSources

Capital Increased to 150 Million YenSources

Nagoya Office OpeningSources

Second Synthetic Building Completed at Fukushima FactorySources

Publication of Toa Academic CommunicationsSources

Completion of second synthesis factorySources

Joined Japan Pharmaceutical Industry AssociationSources

Sales Exceeded 2 Billion YenSources

Third Synthetic Factory Completed at FukushimaSources

Completion of third synthesis factorySources

Capital Alliance with Yamanouchi Pharmaceutical Co., Ltd.Sources

Hiroshima Office OpeningSources

Construction of Fourth Research Building at Fukushima CompletedSources

Sales Exceeded 3 Billion YenSources

Completion of the Synthesis Research BuildingSources

Capital Increased to 300 Million YenSources

Tokyo First Sales Section Yokohama Branch Office OpeningSources

Increased capital to 300 million yen in 1971Sources

Awarded the Minister of Labor Award (3rd National Safety Week Excellent Workplace)Sources

Sendai Sales Office OpeningSources

Start of Two-Day Weekly Rest SystemSources

Material Warehouse Completed at Fukushima FactorySources

Second place in the All Japan Business Group Table Tennis Tournament Women's Soft SectionSources

Hiroshima Sales Office Takamatsu Branch OpeningSources

Taking over the management of Sanzen Pharmaceutical Co., Ltd.Sources

Completion of activated sludge wastewater treatment facility at Fukushima FactorySources

Received Industry Safety Merit Award from the Prime MinisterSources

Received Prime Minister's Award in 1975Sources

Revision of medical fee schedule (prescription fee 500 yen)Sources

Ministry of Health, Labour and Welfare notifies implementation details of GMPSources

Lawsuit filed for quadriceps atrophySources

Completion of the Pollution Prevention Drainage Treatment FacilitySources

Awarded the Prime Minister Award (National Safety Week Industrial Safety Merit)Sources

Sales exceeded 5 billion yenSources

Hiroshima Sales Office Kanazawa Branch OpeningSources

Sales exceeded 5 billion yen in 1976Sources

Implementation of the Material Patent and Pharmaceutical Patent SystemSources

GMP implementationSources

Pharmaceutical Association formulates the Ethical Code for Medical Drug PromotionSources

Kampo medicine formulations extensively listed in the drug price standardSources

Establishment of the National Cardiovascular CenterSources

Installation of West German Stronke-made ampoule filling machine at Fukushima FactorySources

Comprehensive revision of the drug price standard (listing by brand with unified limited listing method)Sources

Opening of Narita AirportSources

Kobe Branch OpeningSources

Publication of attached document collectionSources

Pharmaceutical Association develops training guidelines for medical representativesSources

Enactment of the Law for Relief Fund for Drug Side Effect VictimsSources

Pharmaceutical Association establishes unified drug product codesSources

Start of training system for medical information officersSources

Tokyo First Sales Office Omiya Branch OpeningSources

Osaka Sales Office Kyoto Branch OpeningSources

QC Circle established at Fukushima FactorySources

Pharmaceutical Association Safety Committee drafts voluntary regulations for GLPSources

Legalization of GMPSources

Mandatory bookkeeping for some pharmaceuticalsSources

Completion of the 2nd research buildingSources

Launch of FrandolSources

First conference on coronary failure researchSources

Completion of the Second Research BuildingSources

Establishment of Toei Shoji Co., Ltd.Sources

Opening of Niigata Sales OfficeSources

Opening of Okayama Sales OfficeSources

Decision on new company name "Toa Eiyo Co., Ltd." and new company emblemSources

New company name and emblem usage beginsSources

Sales exceeded 10 billion yenSources

Chiba Sales Office openedSources

Shizuoka Sales Office openedSources

Runner-up in the All Japan Business Group Table Tennis ChampionshipsSources

Tachikawa Sales Office openedSources

IBM computer introduced at headquartersSources

Renamed to Toa Eiyo Co., Ltd.Sources

Third research building completedSources

Completion of the Third Research BuildingSources

Sales exceeded 15 billion yenSources

Computer online connection between headquarters and Fukushima factorySources

Sales exceeded 12 billion yen (changed to net sales display)Sources

Fukushima factory automated warehouse with computer-controlled rack system completedSources

Completion of the Automated WarehouseSources

Morioka Sales Office openedSources

Product packaging design completely changedSources

Sales exceeded 15 billion yenSources

Sakai Sales Office openedSources

Fiscal year changed from December to MarchSources

Table tennis club received the Minister of Education AwardSources

Awarded the Minister of Labor Award (4th National Labor Health and Safety Week Effort Award)Sources

Tokyo Third Branch openedSources

Kyoto Branch openedSources

Takamatsu Branch OpeningSources

Establishment of Academic Department in All BranchesSources

Awarded the Minister of Labor Award (4th National Labor Health and Safety Week Effort Award)Sources

Completion of Tokyo Research InstituteSources

50th Anniversary Ceremony of FoundingSources

In 1993, celebrating 50 years since founding, and marking half a century, we established the Tokyo Research Institute as our first research base in the metropolitan area.Sources

Completion of the Tokyo Research InstituteSources

Mito Sales Office OpeningSources

As a product, we launched the angina treatment drug 'Aitrol Tablets' in 1994.Sources

Introduction of IBM Computer AS400 at Headquarters and Fukushima FactorySources

Completion of Sendai FactorySources

Company Website Launch (for Recruitment)Sources

In 1997, we launched our company website.Sources

55th Anniversary Ceremony and PartySources

Radio Tanpa 'Heart Disease Foundation Ischemic Heart Disease Seminar' StartsSources

In 1998, we started the 'Heart Disease Foundation Ischemic Heart Disease Seminar'.Sources

In 2000, we launched the diabetes medication 'Medett Tablets'.Sources

Fukushima Factory Eye Drop Manufacturing Room RenovationSources

Construction of the Formulation Technology Center completed in 2001.Sources

Completion of the Formulation Technology Center (Fukushima)Sources

In 2002, we launched the heart failure treatment drugs 'Digoxin KY Tablets' and 'Half Digoxin KY Tablets'.Sources

Sendai Factory obtained ISO 14001 certification.Sources

Sendai Factory ISO 14001 Certification AcquisitionSources

Construction of the Synthesis Technology Center completed.Sources

Construction of the training facility 'Quore' completed.Sources

Relocation of Headquarters to Hatchobori, Chuo-ku, TokyoSources

Launch of the web service "Digoxin Dosage Estimation Service"Sources

Despite damage to Fukushima and Sendai caused by the Great East Japan Earthquake, rapid response and cooperation from related parties led to recovery, fulfilling the mission of "stable supply" without causing shortages in the marketSources

Completion of the Synthetic Technology Center (Fukushima)Sources

Revised consumption tax rate (8%)Sources

Registration of "Tomioka Silk Mill" as a World Cultural Heritage siteSources

Enforcement of the Pharmaceuticals and Medical Devices Act (mandatory submission of package inserts)Sources

World's first regenerative medicine using iPS cellsSources

Completion of the Sendai Factory Adhesive Packaging BuildingSources

Opening of the Hokuriku ShinkansenSources

Completion of the Fukushima Plant Utility BuildingSources

Completion of the Fukushima Factory New Warehouse BuildingSources

§07

News

0 ARTICLES

There is no news.

§08

Public records

GOV
National Tax Agency basic information8010001052296
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
トーアエイヨー株式会社
Trade name (kana)
トーアエイヨー
Name in English
Corporation type
301
Address
〒104-0032 東京都中央区八丁堀3丁目10番6号
Postal code
1040032
Prefecture code
13
City code
102
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2018-07-04
Change date
2015-10-05
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
01
Correction type
1
Trade name image ID
Address image ID
Sequence number
2314157
METI gBizINFO8010001052296
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
8010001052296
Trade name
トーアエイヨー株式会社
Trade name (kana)
トーアエイヨー
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
東京都中央区八丁堀3丁目10番6号
Postal code
1040032
Prefecture
東京都
Prefecture code
13
City or district
中央区
City code
102
Street address
八丁堀3丁目10番6号
Organisation type
301
Processing type
71
Correction type
0
Status
Representative
Capital
Employees
300
Employees (male)
Employees (female)
Business summary
医療用医薬品製造販売業
Website URL
http://www.toaeiyo.co.jp
Year founded
Business category
E:製造業
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2026-05-08
Key information
8010001052296
§09

Sources & updates

SOURCES
↑